CD Biosciences Supplies Services for Single-cell Transcriptome Sequencing and Analysis for TME Research

CD Biosciences TME center is a reliable partner dedicated to providing professional tumor microenvironment-related services to customers all over the world. CD BioSciences has extensive experience in tumor microenvironment research and can help scientists with all services and solutions in this field. With rich experience and state-of-the-art technology, CD Biosciences designs practical solutions and implements the changes required by scientists to achieve outstanding results in tumor microenvironment projects. Recently, CD Biosciences announced the release of its single-cell transcriptome sequencing and analysis for TME research.

Single-cell sequencing of the tumor microenvironment studies the transcriptome at the single-cell level. Through transcriptome amplification and high-throughput sequencing, the gene structure and gene expression status of individual cells can be revealed, reflecting the heterogeneity among cells. Compared with population cell sequencing, it is more suitable for solving problems such as the research of a small number of special samples (such as tumor clinical samples) and the analysis of heterogeneous populations. CD Biosciences has established a mature tumor microenvironment center technology platform, has a group of experienced tumor microenvironment research experts and mature technology, provides efficient tumor and microenvironment single-cell sequencing and analysis services for global customers, and helps in tumor and microenvironment research, exploration of microenvironmental heterogeneity, tumor progression study, and anticancer drug discovery.

CD BioSciences' TME research single-cell transcriptome sequencing analysis project includes not only the analysis of gene structure and gene expression level but also the classification of cell subtypes, annotation of tumor genes and transcription factors. In addition, personalized analysis services are also provided, and analysis content can be customized according to customer needs.

CD BioSciences' TME research can facilitate the study of highly heterogeneous cells in the tumor microenvironment, the study of low sample/cell volume, genome-wide mining of gene regulatory networks, and help to gain insight into cell differentiation, cell reprogramming, metastasis and the process of differentiation, as well as the associated gene regulatory network.

“We have established a tumor microenvironment center technology platform with high-performance scientific instruments and high-value solutions to ensure high-quality services and enable scientists to explore the mysteries of life at the level of tumor microenvironment.” said Marcia Brady, the marketing director of CD Biosciences, she also added, “In addition, we can also tailor solutions for you according to your scientific research needs.”

About CD Biosciences

CD BioSciences provides global scientists and researchers with a full range of consulting, design, implementation, management, reporting and analysis services related to the study of the tumor microenvironment. CD BioSciences can help customers solve project problems or open up new research directions in all aspects to speed up research. In addition, we can also customize solutions for you according to your scientific research needs.